Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Diagnostic biomarkers of prostate cancer.

Häggarth L, Hägglöf C, Jaraj SJ, Wester K, Pontén F, Ostman A, Egevad L.

Scand J Urol Nephrol. 2011 Feb;45(1):60-7. doi: 10.3109/00365599.2010.526141.

PMID:
21034352
3.
4.
6.
7.

Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.

Stewart J, Fleshner N, Cole H, Toi A, Sweet J.

J Urol. 2008 May;179(5):1751-5; discussion 1755. doi: 10.1016/j.juro.2008.01.012.

PMID:
18343427
8.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
9.

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).

Jiang Z, Woda BA, Wu CL, Yang XJ.

Am J Clin Pathol. 2004 Aug;122(2):275-89. Review.

PMID:
15323145
10.

Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.

Jiang Z, Woda BA.

Adv Anat Pathol. 2004 Nov;11(6):316-21. Review.

PMID:
15505533
11.

alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer.

Santinelli A, Mazzucchelli R, Barbisan F, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R.

Am J Clin Pathol. 2007 Oct;128(4):657-66.

PMID:
17875519
13.

Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.

Carswell BM, Woda BA, Wang X, Li C, Dresser K, Jiang Z.

Histopathology. 2006 May;48(6):668-73.

PMID:
16681682
14.

Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.

Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI.

Am J Surg Pathol. 2003 Aug;27(8):1128-33.

PMID:
12883245
15.

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z.

Hum Pathol. 2004 Aug;35(8):1008-13.

PMID:
15297968
16.
17.

Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker.

Tischler V, Fritzsche FR, Gerhardt J, Jäger C, Stephan C, Jung K, Dietel M, Moch H, Kristiansen G.

Histopathology. 2010 May;56(6):811-5. doi: 10.1111/j.1365-2559.2010.03535.x. No abstract available.

PMID:
20546348
18.
19.
20.

Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.

Schostak M, Miller K, Krause H, Schrader M, Kempkensteffen C, Kollermann J.

Cancer Detect Prev. 2006;30(5):449-54.

PMID:
17067752

Supplemental Content

Support Center